La cadena de opciones muestra datos clave de las opciones de acciones de Guardforce AI Co a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Guardforce AI Co..

Guardforce AI Co (NASDAQ:GFAI) Bolsa, Cadena de Opciones

Guardforce AI Co

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Guardforce AI Co., Limited - Ordinary Shares

Guardforce AI Co Ltd

<p>Morgan Stanley  analyst Mike Cyprys   maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Overweight and raises the price target from $1245 to $1261.</p>


News

Price Target

Analyst Ratings

Morgan Stanley Maintains Overweight on BlackRock, Raises Price Target to $1261

<ul>
<li>The U.S. Department of Commerce has awarded TI up to $1.6 billion in CHIPS Act funding to support three new 300mm semiconductor wafer fabs under construction in Texas and Utah.</li>
<li>TI also expects to receive an estimated $6 billion to $8 billion from the U.S. Department of the Treasury's Investment Tax Credit for qualified U.S. manufacturing investments.</li>
<li>The company will also receive up to $10 million to support workforce development.</li>
</ul>
<p>LEHI, Utah and SHERMAN, Texas, Dec. 20, 2024 /PRNewswire/ -- Texas Instruments (TI) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) and the U.S. Department of Commerce today announced an award agreement of up to $1.6 billion in direct funding through the U.S. CHIPS and Science Act, following the preliminary memorandum of terms announced in August 2024. The funding will help support three of TI's new 300mm wafer fabs currently under construction in Texas and Utah.&nbsp;Support from the CHIPS Act, including the 25% investment tax credit, will help TI provide a geopolitically dependable supply of essential analog and embedded processing semiconductors.</p>


Contracts

The U.S. Department Of Commerce Has Awarded TI Up To $1.6B In CHIPS Act Funding To Support 3 New 300mm Semiconductor Wafer Fabs Under Construction In Texas And Utah. TI Also Expects To Receive An ~$6B-$8B From The U.S. Department Of The Treasury's Investment Tax Credit For Qualified U.S. Manufacturing Investments; Will Also Receive Up To $10M To Support Workforce Development

AMZN

GOOG

GOOGL

SNAP

Potential TikTok Bidder Frank McCourt Says He Is Seeking A New CEO For The Company; TikTok Could Earn Revenue From Ecommerce And Data Licensing, Reduce Reliance On Ads

WIIM

IQVIA Holding shares are trading higher after Stephens & Co initiated coverage on the stock with an Overweight rating on the stock and announced a $250 price target.

<p><a href="https://x.com/JakeSherman/status/1870162466702770527" title="https://x.com/JakeSherman/status/1870162466702770527">https://x.com/JakeSherman/status/1870162466702770527</a></p>


Macro Economic Events

Politics

Economics

General

Punchbowl's Jake Sherman Posts On X "JOHNSON said he has spoken to President-elect TRUMP about his new plan." "SCALISE said this about timing: "We're going to be deciding that amongst the membership. there's a plan that gets us there today, if not, we'll do it tomorrow. "

<p>Morgan Stanley  analyst Joseph Moore   maintains Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) with a Equal-Weight and lowers the price target from $169 to $158.</p>


Morgan Stanley Maintains Equal-Weight on Advanced Micro Devices, Lowers Price Target to $158

<p>U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 300 points on Friday.</p>
<p>The Dow traded up 1.82% to 43,111.11 while the NASDAQ rose 1.77% to 19,714.27. The S&amp;P 500 also rose, gaining, 1.76% to 5,970.36.</p>
<p>Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></p>
<p><strong>Leading and Lagging Sectors</strong><br /><br />Real estate shares jumped by 2.6% on Friday.</p>
<p>In trading on Friday, consumer staples shares rose by just 0.6%.</p>
<p><strong>Top Headline</strong></p>
<p>The U.S. personal consumption expenditures price index rose 0.1% month-over-month in November down from 0.2% in each of the prior two months and compared to market estimates of 0.2%.</p>
<p><strong>Equities Trading UP</strong><br />&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<ul>
<li><strong>Humacyte, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) shares shot up 40% to $4.8500 after the company announced FDA approval for SYMVESS for treating extremity vascular injuries. HC Wainwright &amp; Co. raised its price target on the stock from $12 to $15.</li>
<li>Shares of <strong>Personalis, Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>)got a boost, surging 25% to $6.55 after the company and Moderna recently announced a multi-year extension to continue utilizing the Personalis ImmunoID NeXT platform and technology for V940/mRNA-4157. The company also announced an investment from Merck.</li>
<li><strong>Taoping Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) shares were also up, gaining 31% to $0.4153 after the company announced it received an additional 180 calendar days for compliance with the Nasdaq minimum bid price requirement.</li>
</ul>
<p><strong>Equities Trading DOWN</strong></p>
<ul>
<li><strong>Cyngn Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares dropped 74% to $0.4173 as the company reported the pricing of $20.0 million follow on offering.</li>
<li>Shares of <strong>Galectin Therapeutics Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GALT#NASDAQ">GALT</a>) were down 53% to $0.9499 after the company announced top-line results of its NAVIGATE clinical trial and confirmed belapectin did not achieve statistical significance.</li>
<li><strong>Novo Nordisk A/S </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) was down, falling 17% to $86.01. The company announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE program.</li>
</ul>
<p><strong>Commodities</strong><br /><br />In commodity news, oil traded down 0.6% to $68.97 while gold traded up 1.5% at $2,645.80.</p>
<p>Silver traded up 1.6% to $29.890 on Friday, while copper rose 0.4% to $4.0925.</p>
<p><strong>Euro zone</strong></p>
<p>European shares were lower today. The eurozone's STOXX 600 dipped 0.99%, Germany's DAX fell 0.59% and France's CAC 40 declined 0.37%. Spain's IBEX 35 Index fell 0.10%, while London's FTSE 100 fell 0.25%.</p>
<p>Consumer confidence in the Eurozone declined by 0.8 points to a reading of -14.5 in December.</p>
<p><strong>Asia Pacific Markets</strong></p>
<p>Asian markets closed lower on Friday, with Japan's Nikkei 225 falling 0.29%, Hong Kong's Hang Seng Index falling 0.16%, China's Shanghai Composite Index declining 0.06% and India's BSE Sensex falling 1.49%.</p>
<p><strong>Economics</strong></p>
<ul>
<li>The University of Michigan consumer sentiment rose to 74 in December, recording the highest level since April, and versus a reading of 71.8 in November.</li>
<li>U.S. personal income increased by 0.3% month-over-month in November compared to a revised 0.7% gain in October.</li>
<li>Personal spending increased by 0.4% to an annualized rate of $20.2 trillion in November.</li>
<li>The U.S. personal consumption expenditures price index rose 0.1% month-over-month in November down from 0.2% in each of the prior two months and compared to market estimates of 0.2%.</li>
</ul>
<p><strong>Now Read This: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42616304/top-3-risk-off-stocks-that-may-collapse-this-month">Top 3 Risk Off Stocks That May Collapse This Month</a></strong></li>
</ul>


Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

GALT

HUMA

PSNL

TAOP

Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher

White House Says Republicans Need To Stick With Bipartisan Deal To Keep The Government Open

AVGO

Broadcom shares are trading higher. Morgan Stanley maintained its Overweight rating on the stock and raised its price target from $233 to $265

Econ #s

U.S. Baker Hughes Oil Rig Count +1 At 483; U.S. Baker Hughes NatGas Rig Count -1 At 102

<p>Morgan Stanley  analyst Joseph Moore   maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Equal-Weight and raises the price target from $102 to $120.</p>


MRVL

Morgan Stanley Maintains Equal-Weight on Marvell Tech, Raises Price Target to $120

COLB

CNBC Halftime Report Final Trades: Freeport-McMoRan, Columbia Banking System, The Procter & Gamble Company, Target

SSNLF

U.S. Commerce Department Finalizes Up To $4.745B Chips Subsidy For Samsung Electronics, Significantly Less Than Initially Proposed; U.S. Finalizes Up To $1.6B Subsidy For Texas Instruments For Factories In Texas And Utah

<p>Morgan Stanley  analyst Joseph Moore   maintains Astera Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) with a Overweight and raises the price target from $94 to $142.</p>


ALAB

Morgan Stanley Maintains Overweight on Astera Labs, Raises Price Target to $142

<p>10 analysts have expressed a variety of opinions on Paychex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYX#NASDAQ">PAYX</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">9</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Paychex and provided 12-month price targets. The average target is $138.9, accompanied by a high estimate of $148.00 and a low estimate of $130.00. Witnessing a positive shift, the current average has risen by 8.77% from the previous average price target of $127.70.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734717653_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Paychex among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$148.00</td>
<td>$148.00</td>
</tr>
<tr>
<td>Tien-Tsin Huang</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$139.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Bryan Bergin</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Hold</td>
<td>$131.00</td>
<td>$126.00</td>
</tr>
<tr>
<td>David Grossman</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$141.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$130.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Ashish Sabadra</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$148.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Kevin Mcveigh</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$142.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>James Faucette</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$133.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Peter Christiansen</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$145.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Ramsey El-Assal</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$132.00</td>
<td>$118.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Paychex. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Paychex compared to the broader market.</li>
<li><strong>Price Targets:</strong> Understanding forecasts, analysts offer estimates for Paychex's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
<p>To gain a panoramic view of Paychex's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PAYX/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Paychex analyst ratings.</strong></a></p>
<h2>Get to Know Paychex Better</h2>
<p>Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, founded in 1971, services over 745,000 clients and pays 1 in 12 US private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.</p>
<h3>Key Indicators: Paychex's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, Paychex showcased positive performance, achieving a revenue growth rate of <strong>2.53%</strong> as of 31 August, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.</p>
<p><strong>Net Margin:</strong> Paychex's net margin is impressive, surpassing industry averages. With a net margin of <strong>32.42%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Paychex's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>11.17%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Paychex's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>4.1%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.23</strong>, Paychex adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<h2>Understanding the Relevance of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


PAYX

Demystifying Paychex: Insights From 10 Analyst Reviews

<p>Analysts' ratings for Brookdale Senior Living (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKD#NYSE">BKD</a>) over the last quarter vary from bullish to bearish, as provided by 7 analysts.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $7.86, with a high estimate of $9.00 and a low estimate of $6.00. Highlighting a 3.2% decrease, the current average has fallen from the previous average price target of $8.12. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734717645_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The standing of Brookdale Senior Living among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tao Qiu</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Brian Tanquilut</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$8.00</td>
<td>-</td>
</tr>
<tr>
<td>Tao Qiu</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$9.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Joanna Gajuk</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$6.00</td>
<td>$7.75</td>
</tr>
<tr>
<td>Tao Qiu</td>
<td>Macquarie</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$8.00</td>
<td>$8.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Brookdale Senior Living. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Brookdale Senior Living compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Brookdale Senior Living's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Brookdale Senior Living's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BKD/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Brookdale Senior Living analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Discovering Brookdale Senior Living: A Closer Look</h2>
<p>Brookdale Senior Living Inc operates senior living communities throughout the United States. The company has three reportable segments; Independent Living; Assisted Living and Memory Care; and Continuing Care Retirement Communities (CCRs). Majority of the revenue is generated from the Assisted Living and Memory Care segment that offers housing and assistance with activities of daily living to its customers. The company generates revenue in the form of Resident Fees which it receives in exchange for the services provided, and in the form of management fee from certain communities under contract, in exchange for the management services provided.</p>
<h3>Understanding the Numbers: Brookdale Senior Living's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Brookdale Senior Living's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>3.91%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of <strong>-6.47%,</strong> the company may need to address challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Brookdale Senior Living's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>-16.02%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-0.89%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of <strong>17.72</strong>, caution is advised due to increased financial risk.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where Brookdale Senior Living Stands With Analysts

<p>With a limited number of trading days left to close out the 2024 year, one last question on the mind of investors is whether there will be a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42547783/santa-claus-rally-is-facing-some-indigestion-says-ubs-expert-the-market-is-basically-taking-a-little-bit-of-a-probably-well-needed-pause">Santa Claus rally.</a></p>
<p>Here's a look at what Benzinga readers said in a new poll.</p>
<p><strong>What Happened:</strong> The term<a href="https://www.benzinga.com/topic/santa-claus-rally"> Santa Claus rally </a>was first used by <strong>Yale Hirsch </strong>in 1972 in the Stock Trader's Almanac.</p>
<p>The term is <a href="https://www.stocktradersalmanac.com/Alert/20220104.aspx">associated </a>with the last five trading days of a year and the first two days of the following year and often see higher prices for numerous reasons.</p>
<p>This time of the year includes year-end portfolio rebalancing, holiday sales data and optimism for the new year ahead, which can often lead to strong returns for major stock market indexes.</p>
<p><strong>"Do you think there will be a Santa Rally this year," Benzinga recently asked readers.</strong></p>
<p>The results were:</p>
<ul>
<li>Yes, I expect a rally: 57%</li>
<li>No, I don't think so: 43%</li>
</ul>
<p>The poll was fairly evenly split with the majority saying they expect a Santa Claus rally to end 2024 and kick-start 2025.</p>
<p><strong>Read Also: <a href="https://www.benzinga.com/markets/equities/24/12/42259188/tech-stocks-set-for-strong-santa-rally-as-wall-street-looks-for-an-end-to-regulatory-spider-web-in-the-trump-era-says-dan-ives">Tech Stocks Set For Strong Santa Rally As Wall Street Looks For An End To &#8216;Regulatory Spider Web&#8217; In The Trump Era, Says Dan Ives</a></strong></p>
<p><strong>Why It's Important: </strong>The expectation for a Santa Claus rally comes with major stock market indexes enjoying a strong 2024 and could add to their year-to-date gains.</p>
<p>Here are the current year-to-date returns of three of the largest market index ETFs.</p>
<ul>
<li><strong>SPDR S&amp;P 500 ETF Trust </strong>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>): +23.8%</li>
<li><strong>Invesco QQQ Trust</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>): +28.1%</li>
<li><strong>SPDR Dow Jones Industrial Average ETF</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>): +12.7%</li>
</ul>
<p>Data from the Stock Trader's Almanac found that from 1950 through 2022 a Santa Claus rally occurred 58 times, or 79.4% of the time. The average gain in the S&amp;P 500 during the Santa Clause rally those years was 1.4%.</p>
<p><a href="https://www.benzinga.com/24/12/42352997/santa-rally-here-are-10-sp-500-stocks-that-historically-outperformed-in-decembers-second-half">Benzinga recently shared</a> that data from LPL Financial showed that December is the second-best month for S&amp;P 500 returns since 1950, with an average return of 1.6%. December trails only November since 1950, with an average S&amp;P 500 return of 1.8%. The strong December returns are often weighted to the second half of the month. </p>
<p>While many people will get presents to celebrate the Christmas holiday, investors could get the gift of higher stock prices based on historical returns and the Benzinga reader poll.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/24/12/42352997/santa-rally-here-are-10-sp-500-stocks-that-historically-outperformed-in-decembers-second-half">Santa Rally: 10 S&amp;P 500 Stocks That Outperform In December&#8217;s Second Half</a></strong></li>
</ul>
<p><em>The study was conducted by Benzinga from Dec. 18 through Dec. 19, 2024, and included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 241 adults.</em></p>

<p><em>Photo: Shutterstock</em></p>


Broad U.S. Equity ETFs

Education

Exclusives

ETFs

SPDR Dow Jones Industrial Average ETF Trust

Santa Claus Rally In 2024? Poll Shows Investors Split On End Of Year Returns, 57% Say This…

<p>Analysts' ratings for BankUnited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKU#NYSE">BKU</a>) over the last quarter vary from bullish to bearish, as provided by 10 analysts.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $42.7, a high estimate of $49.00, and a low estimate of $37.00. Witnessing a positive shift, the current average has risen by 11.2% from the previous average price target of $38.40.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734717636_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>A clear picture of BankUnited's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$44.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>David Rochester</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$49.00</td>
<td>$42.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$45.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Wood Lay</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$45.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$42.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$48.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Sector Perform</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Timur Braziler</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$38.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$39.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>David Chiaverini</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Neutral</td>
<td>$40.00</td>
<td>$39.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to BankUnited. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of BankUnited compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts explore the dynamics of price targets, providing estimates for the future value of BankUnited's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into BankUnited's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BKU/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on BankUnited analyst ratings.</strong></a></p>
<h2>Delving into BankUnited's Background</h2>
<p>BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located primarily throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.</p>
<h3>A Deep Dive into BankUnited's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> BankUnited's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>5.96%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> BankUnited's net margin excels beyond industry benchmarks, reaching <strong>23.58%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> BankUnited's ROE excels beyond industry benchmarks, reaching <strong>2.2%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> BankUnited's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>0.17%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>1.53</strong>, BankUnited faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Glimpse Into The Expert Outlook On BankUnited Through 10 Analysts

<p>In the preceding three months, 37 analysts have released ratings for ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">13</td>
<td align="right">21</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">6</td>
<td align="right">11</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">3</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $1054.78, along with a high estimate of $1300.00 and a low estimate of $900.00. This upward trend is evident, with the current average reflecting a 11.89% increase from the previous average price target of $942.68.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734717625_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>A clear picture of ServiceNow's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$1200.00</td>
<td>$1000.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1210.00</td>
<td>$1070.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$1100.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$1300.00</td>
<td>$1025.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1250.00</td>
<td>$1150.00</td>
</tr>
<tr>
<td>Brian Schwartz</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1150.00</td>
<td>$1020.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$1250.00</td>
<td>$1100.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$1150.00</td>
<td>$1075.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1070.00</td>
<td>$980.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1150.00</td>
<td>$1050.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$1071.00</td>
<td>$1068.00</td>
</tr>
<tr>
<td>Peter Weed</td>
<td>Bernstein</td>
<td>Raises</td>
<td>Outperform</td>
<td>$913.00</td>
<td>$906.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1045.00</td>
<td>$985.00</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$1025.00</td>
<td>$1000.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$990.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Jason Ader</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1040.00</td>
<td>$1020.00</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1000.00</td>
<td>$950.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1050.00</td>
<td>$1025.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1000.00</td>
<td>$850.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1000.00</td>
<td>$980.00</td>
</tr>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$950.00</td>
<td>$820.00</td>
</tr>
<tr>
<td>Rob Oliver</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$975.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$1000.00</td>
<td>$850.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$1075.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$900.00</td>
<td>$780.00</td>
</tr>
<tr>
<td>Keith Weiss</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$960.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$1000.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$1068.00</td>
<td>$915.00</td>
</tr>
<tr>
<td>Brian Schwartz</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1020.00</td>
<td>$825.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$980.00</td>
<td>$850.00</td>
</tr>
<tr>
<td>Patrick Walravens</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$1000.00</td>
<td>$850.00</td>
</tr>
<tr>
<td>Samad Samana</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$1100.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$980.00</td>
<td>$890.00</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$1025.00</td>
<td>$860.00</td>
</tr>
<tr>
<td>Kirk Materne</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$950.00</td>
<td>$850.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$1055.00</td>
<td>$900.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$1025.00</td>
<td>$935.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ServiceNow. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of ServiceNow compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts gauge the dynamics of price targets, providing estimates for the future value of ServiceNow's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of ServiceNow's market position. Stay informed and make well-informed decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NOW/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on ServiceNow analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind ServiceNow</h2>
<p>ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.</p>
<h3>Financial Milestones: ServiceNow's Journey</h3>
<p><strong>Market Capitalization:</strong> Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.</p>
<p><strong>Revenue Growth:</strong> ServiceNow's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately <strong>22.25%</strong>. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> ServiceNow's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>15.45%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> ServiceNow's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>4.81%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> ServiceNow's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>2.36%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> ServiceNow's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.24</strong>.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Assessing ServiceNow: Insights From 37 Financial Analysts

<p><i>Company will implement innovative Mission&nbsp;Partner Environment to securely share information with global mission partners</i></p>
<p>FALLS CHURCH, Va., Dec. 20, 2024 /PRNewswire/ -- General Dynamics Information Technology (GDIT), a business unit of General Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GD#NYSE">GD</a>), announced today it was awarded a new $5.6 billion contract by the Air Force Mission Partner Capabilities Office. The single award, indefinite-delivery indefinite-quantity contract, <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4329881-1&amp;h=2152613664&amp;u=https%3A%2F%2Fwww.defense.gov%2FNews%2FContracts%2FContract%2FArticle%2F3962730%2F&amp;a=awarded">awarded</a> in November, has a five-year base period and a five-year option.</p>
<p>Mission Partner Environments (MPEs) enable the military and its trusted partners to securely communicate, collaborate and share information at multiple levels of classification in real time so decision makers can rapidly adapt to changing mission dynamics.</p>
<p>Under the contract, GDIT will modernize, integrate, operate and sustain the Department of Defense's MPE. The company will provide a portfolio of services including mission, cyber and enterprise IT services and infrastructure. This contract will also advance interoperability – the ability to seamlessly connect multiple systems together – with U.S. government and non-government entities and international coalition partners in support of the National Defense Strategy.</p>


General Dynamics Information Technology Awarded A New 5-Year $5.6B Contract By The Air Force Mission Partner Capabilities Office To Implement Innovative Mission Partner Environment To Securely Share Information With Global Mission Partners

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>Everyone&rsquo;s current favorite antagonist, Federal Reserve Chair Jerome Powell, might be turning the tide with his latest comment on the economy. In a recent address, He stated, &ldquo;I don&rsquo;t see the &lsquo;stag&rsquo; or the &lsquo;flation&rsquo;,&rdquo; dispelling concerns about a 1970s-like stagflation. Hence, an economic recovery is well within sight, which bodes well for undervalued AI <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>.</p>



<p><a href="https://investorplace.com/industries/technology/artificial-intelligence/">AI stocks</a> have been panned in recent weeks after taking the stock market to record highs last year. However, few, if any, can take away the AI industry&rsquo;s disruptive long-term potential. As I&rsquo;ve mentioned multiple times in my articles of late, we&rsquo;re still in the early stages of what promises to be a long and illustrious era for AI.</p>



<p>The Magnificent Seven hogged the spotlight last year, overshadowing the impressive strides made by undervalued AI penny stocks. Here are three that impress the most but caution is advised considering the speculative nature of these investments.</p>



<h2>Guardforce AI (GFAI)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/ai1600b-300x169.jpg" alt="AI stocks an intelligent robot figure representing ai stocks, investing for the next decade. Artificial Intelligence Stocks"><div>Source: Shutterstock</div></div><p><strong>Guardforce AI</strong>&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/gfai-stock-quote/"><strong>GFAI</strong></a>) is an interesting AI penny stock, which leverages disruptive technology to deliver robust robotics-based security solutions. This unique focus on robotics-based security positions it ahead of its competition and as a frontrunner in the field.</p>



<p>Moreover, its recent quarterly performances show healthy single-digit revenue growth, while comfortably beating analyst estimates. Additionally, its <a href="https://seekingalpha.com/symbol/GFAI/cash-flow-statement">free cash flow balance</a> stands at an impressive $11 million as of last year, 148% higher than the prior-year period.</p>



<p>Furthermore, the firm is moving forward with strategic partnerships and acquisitions to further strengthen its positioning. It recently bought out robot-related business assets from&nbsp;<strong>Shenzhen Kewei Robot Technology </strong>which could significantly enhance GFAI&rsquo;s Robot-as-a-Service (RaaS) sales and capabilities. Also, its <a href="https://s3.amazonaws.com/b2icontent.irpass.cc/2688/rl120322.pdf">collaboration with <strong>Concorde Security</strong>&nbsp;</a>in Singapore is another feather in its proverbial cap. Concorde expects GFAI&rsquo;s robotic security solutions to effectively manage visitors while performing routine tasks such as janitorial duties.&nbsp; Despite the positives GFAI stock hasn&rsquo;t struck a chord with investors yet, but offers superb long-term potential.</p>



<h2>Inuvo (INUV)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/06/telecommunications1600-300x169.png" alt="Rack Mounted Servers In A Server Room, Server rack audio cable. Severs computer in a rack at the large data center. Fiber Optical connector interface for Cards Equipment DWDM telecommunications. KLR stock"><div>Source: Funtap / Shutterstock.com</div></div><p>Why spend 30 cents on a gumball when you could pick up <strong>Inuvo</strong>&nbsp;(NYSEAMERICAN:<a href="https://investorplace.com/stock-quotes/inuv-stock-quote/"><strong>INUV</strong></a>) stock and chew on even bigger returns?</p>



<p>It wasn&rsquo;t like that for communication services firm Inuvo, though. It traded 99.5% lower than its all-time high price of $60.80. INUV stock has fallen out of favor with investors for a while, having shed more than 50% of its value in the past decade.</p>



<p>However, it ranks among the few firms revitalizing themselves last year through AI-driven initiatives. Inuvo made the rounds last year due to its powerful <a href="https://inuvo.com/intentkey/">AI-based consumer intent recognition platform</a> in IntentKey. &nbsp;</p>



<p>The platform essentially mimics the human brain in associating ideas, emotions, objects, among other things for brands to effectively target the right audience. Moreover, the advertising market is back, adding to the stock&rsquo;s attractiveness.&nbsp; Recent results have shown a healthy uptick in sales growth, while its <a href="https://seekingalpha.com/symbol/INUV/momentum/performance">stock price is up 75%</a> in the past six months.</p>



<h2>Predictive Oncology (POAI)</h2>



<div><img width="300" height="165" src="https://investorplace.com/wp-content/uploads/2018/11/pharmacymsn-300x165.jpg" alt="a hand grabbing a prescription from a shelf full of drugs"><div>Source: Shutterstock</div></div><p><strong>Predictive Oncology</strong>&nbsp;(NASDAQ:<strong><a href="https://investorplace.com/stock-quotes/poai-stock-quote/" target="_blank">POAI</a></strong>) is another moonshot AI penny stock play in the pharmaceutical space. It&rsquo;s a company that uses the power of AI to significantly improve outcomes in the drug discovery process. Without getting into the boring specifics, the bottom line is that the firm helps develop incredibly effective medical treatments more efficiently and accurately. Consequently, treatments can become more personalized and effective for a diverse population.</p>



<p>A bet on the company&nbsp;is a bet on the robust growth expected in the AI-led drug discovery market. According to a MarketsandMarkets report, the sector is projected to grow from&nbsp;<a target="_blank" href="https://www.marketsandmarkets.com/Market-Reports/ai-in-drug-discovery-market-151193446.html#:~:text=The%20size%20of%20global%20AI,40.2%25%20from%202023%20to%202028.">$0.9 billion in 2023 to $4.9 billion by 2028</a>, at a 40.2% CAGR over a five-year period.</p>



<p>Hence, there is a&nbsp;growing trend in the pharma sphere to employ AI in the research and development process, positioning POAI stock for healthy long-term gains.</p>



<p><em>On the date of publication, Muslim Farooque did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a></em>.</p>
<div><p>Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor&rsquo;s of science degree in applied accounting from Oxford Brookes University.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/05/the-3-most-undervalued-ai-penny-stocks-to-buy-in-may-2024/">The 3 Most Undervalued AI Penny Stocks to Buy in May 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

The 3 Most Undervalued AI Penny Stocks to Buy in May 2024

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., Limited has announced a significant expansion in Thailand by securing a 5-year c...

Guardforce AI Expands Cash Center Operations in Thailand

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., Limited, a company incorporated in the Cayman Islands, has registered an offerin...

Guardforce AI Announces Registered Share Offering

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., a provider of integrated security and AI solutions, has significantly expanded i...

Guardforce AI Broadens Reach in Asia Pacific Retail

Warning: GFAI is at high risk of performing badly

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., an established provider of integrated security and AI solutions, will be present...

Guardforce AI to Showcase at Global Investment Conference

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., Limited has announced a new partnership with Outside The Box Capital Inc., in wh...

Guardforce AI Co. Enhances Marketing with Equity Deal

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., Limited has reported a decrease in total assets to $36.2 million as of June 2024...

Guardforce AI Reports Decreased Assets

Guardforce AI Co (GFAI) has released an update. Guardforce AI Co., Limited has announced the immediate departure of Mr. Kee Yun Kwan from his role ...

Guardforce AI Announces COO Departure

Guardforce announced a significant advancement in its collaboration with Librum Technologies, a Massachusetts based technology company founded by l...

Guardforce AI accelerates AI agen capabilities through collaboration

GFAI

INUV

POAI

Events

Press Releases

Guardforce to Present at the Planet MicroCap Showcase: VEGAS 2024 on May 1, 2024

Guardforce AI Reports Record Revenue of $36.3 Million for 2023

Guardforce AI Launches AI Robotic Solution 'LinguaBot' Through Strategic Partnership with iApp Technology

Guardforce AI expands in Thailand with new LinguaBot solution as it addresses AI demand

Guardforce AI Secures 5-Year Contract to Operate Consolidated Cash Center in Thailand, Enhancing Comprehensive Service Capabilities Along with AI Solutions for Retail Clients

Comments

Guardforce AI Co

Guardforce AI Co (GFAI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL